These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 10459349)
41. MULTIPLE NEUROENDOCRINE NEOPLASIA IN A PATIENT WITH TYPE I NEUROFIBROMATOSIS (NF1): REPORT OF A NEW MUTATION (NF1, EXONS 2-30 DELETION) AND LITERATURE REVIEW. Kanno DT; Mattos RLM; Campos FG; Siqueira RM; Carvalho RB; Real Martinez CA Arq Bras Cir Dig; 2023; 35():e1702. PubMed ID: 36629684 [TBL] [Abstract][Full Text] [Related]
42. Concomitant variants in NF1, LZTR1 and GNAZ genes probably contribute to the aggressiveness of plexiform neurofibroma and warrant treatment with MEK inhibitor. Cohen-Barak E; Toledano-Alhadef H; Danial-Farran N; Livneh I; Mwassi B; Hriesh M; Zagairy F; Gafni-Amsalem C; Bashir H; Khayat M; Warrour N; Sher O; Marom D; Postovsky S; Dujovny T; Ziv M; Shalev SA Exp Dermatol; 2022 May; 31(5):775-780. PubMed ID: 34913528 [TBL] [Abstract][Full Text] [Related]
43. Fluorescence in situ hybridization analysis of allelic losses involving the long arm of chromosome 17 in NF1-associated neurofibromas. De Luca A; Bernardini L; Ceccarini C; Sinibaldi L; Novelli A; Giustini S; Daniele I; Calvieri S; Mingarelli R Cancer Genet Cytogenet; 2004 Apr; 150(2):168-72. PubMed ID: 15066327 [TBL] [Abstract][Full Text] [Related]
44. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth. Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044 [TBL] [Abstract][Full Text] [Related]
45. Giant plexiform neurofibroma in a patient with neurofibromatosis type I. Rallis E; Ragiadakou D Dermatol Online J; 2009 May; 15(5):7. PubMed ID: 19624985 [TBL] [Abstract][Full Text] [Related]
46. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Eisenbarth I; Beyer K; Krone W; Assum G Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298 [TBL] [Abstract][Full Text] [Related]
47. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: Tritto V; Ferrari L; Esposito S; Zuccotti P; Bianchessi D; Natacci F; Saletti V; Eoli M; Riva P Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31694342 [TBL] [Abstract][Full Text] [Related]
48. Two novel mutations in exons 19a and 20 and a BsaBI [correction of BsaI] polymorphism in a newly characterized intron of the neurofibromatosis type 1 gene. Klose A; Robinson N; Gewies A; Kluwe L; Kaufmann D; Buske A; Tinschert S; Peters H Hum Genet; 1998 Mar; 102(3):367-71. PubMed ID: 9544853 [TBL] [Abstract][Full Text] [Related]
49. Hereditary spinal neurofibromatosis: a rare form of NF1? Poyhonen M; Leisti EL; Kytölä S; Leisti J J Med Genet; 1997 Mar; 34(3):184-7. PubMed ID: 9132486 [TBL] [Abstract][Full Text] [Related]
50. Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas. Peters N; Waha A; Wellenreuther R; Friedrich RE; Mautner VF; Hoffmeyer S; Lenartz D; Schramm J; Wiestler OD; von Deimling A Acta Neuropathol; 1999 Jun; 97(6):547-51. PubMed ID: 10378372 [TBL] [Abstract][Full Text] [Related]
51. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445 [TBL] [Abstract][Full Text] [Related]
52. [From gene to disease; neurofibromatosis type 1]. de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174 [TBL] [Abstract][Full Text] [Related]
53. Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells. Fishbein L; Eady B; Sanek N; Muir D; Wallace MR Cancer Genet Cytogenet; 2005 Mar; 157(2):181-6. PubMed ID: 15721644 [TBL] [Abstract][Full Text] [Related]
54. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic]. Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360 [TBL] [Abstract][Full Text] [Related]
55. [Tumor reduction of plexiform neurofibroma in the craniofacial and neck area]. Friedrich RE; Gehrke G; Giese M; Mautner VF; Schmelzle R Mund Kiefer Gesichtschir; 1998 May; 2 Suppl 1():S86-90. PubMed ID: 9658829 [TBL] [Abstract][Full Text] [Related]
56. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999 [TBL] [Abstract][Full Text] [Related]
57. Association between benign and malignant peripheral nerve sheath tumors in NF1. Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787 [TBL] [Abstract][Full Text] [Related]
58. Oral manifestations of neurofibromatosis type 1 in children with facial plexiform neurofibroma: report of three cases. Cunha KS; Rozza-de-Menezes RE; Andrade RM; Almeida L; Janini M; Geller M J Clin Pediatr Dent; 2015; 39(2):168-71. PubMed ID: 25823487 [TBL] [Abstract][Full Text] [Related]
59. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors. Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612 [TBL] [Abstract][Full Text] [Related]
60. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M; J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]